S&P 500 Consumer Staples Sector SEC Filings — October 28, 2026

Q3 net operating revenues up 7.4% YoY to $13,380 Million and diluted EPS up 8.1% to $0.93; nine-month net income attributable to shareowners up 14.1% to $12,358 Million

Q3 other income (loss) improved to $(155) Million from $(237) Million YoY, a narrowing loss

Q3 SG&A rose about 9.9% to $3,975 Million from $3,618 Million, outpacing 7.4% revenue growth, a margin headwind

Q3 comprehensive income fell 17.4% to $3,545 Million from $4,288 Million, driven by a $(668) Million FX translation adjustment versus $437 Million a year earlier

Year-to-date dividends paid nearly doubled to $6,842 Million from $4,391 Million, signalling a heavy shareholder return tilt

Exchange offers for up to $7.0 billion of Kenvue notes extended to 5:00 p.m. NYC time on November 2, 2026, with requisite consents received October 9, 2026, indicating the Kenvue acquisition is advancing toward settlement

10% owner trust sold 7,547 shares at $163.61 (~$1.23M), 11 transactions total, holding 486,119 shares afterward; executed under a Rule 10b5-1 plan, a routine pattern with limited conviction signal

Sales executed at prices between $165.83 and $167.63 across tranches, with the trust continuing to sell into a rising price range

Exchange offer expiration has already been extended once from October 27 to November 2, 2026, and is subject to further extension, signalling settlement timing risk on up to $7.0 billion of notes

SG&A grew about 9.9% YoY against 7.4% revenue growth, a negative operating leverage signal

Q3 FX translation swung to a $(668) Million hit from a $437 Million gain a year earlier, a roughly $1.1 Billion swing that dragged comprehensive income down 17.4%

Dividends paid nearly doubled YTD to $6,842 Million from $4,391 Million; if not matched by cash generation, this could strain balance sheet flexibility

The 10% owner trust sold across 11 transactions at prices climbing to $167.63, reducing a controlling-style position, though executed under a 10b5-1 plan

Kenvue indenture amendments become operative only upon settlement, so if the acquisition fails to close, the consent solicitation provides no benefit and the exchange would unwind

Requisite consents already obtained on October 9, 2026 and exchange offers extended to November 2, 2026, with acquisition settlement as the trigger; a clean close would reset Kimberly-Clark's portfolio scale in personal care

Nine-month net income up 14.1% against Q3 EPS growth of 8.1% suggests sustained profit growth beyond the current quarter if FX headwinds stabilise

Q3 other loss narrowed to $(155) Million from $(237) Million, a roughly 35% improvement that could continue to lift pre-tax results if the trend persists

The near-doubling of YTD dividends to $6,842 Million reflects a strong return posture, supporting income-oriented holders

Continued trust selling at a rising price range may cap near-term upside, but the 10b5-1 nature implies scheduled rather than discretionary selling, which could offer a clearer entry once the program completes

Coca-Cola's Q3 FX translation swing of roughly $1.1 Billion versus the prior year demonstrates how foreign currency is compressing reported comprehensive income for multinational consumer staples, implying investors should look through to constant-currency operating results

Coca-Cola's SG&A growth of about 9.9% against 7.4% revenue growth is consistent with a sector-wide cost pressure theme that could erode margins if pricing power softens

Kimberly-Clark's pursuit of Kenvue reflects the strategic consolidation theme in personal care and household products, where scale is being bought to defend share

Coca-Cola's YTD dividend payout nearly doubling highlights capital return as a priority across large-cap staples, competing with reinvestment and M&A for free cash flow

Hershey's trust selling under a 10b5-1 plan reflects structured, pre-planned liquidity management by large holders rather than a sector-wide directional bet

Expiration currently 5:00 p.m. NYC time on November 2, 2026, subject to further extension; watch for any additional extension or settlement announcement

Monitor whether SG&A growth moderates below revenue growth in the next quarter and whether the FX translation hit reverses

Track free cash flow against the nearly doubled YTD dividend payout of $6,842 Million

Watch for completion of the 10b5-1 program and the trust's remaining 486,119 shares as a potential overhang signal

Monitor consent amendment operation and the acquisition closing timeline tied to the exchange offers

Track whether FX translation headwinds persist in the next filing cycle across multinational peers